Monitoring in real time the formation and removal of biofilms from clinical related pathogens using an impedance-based technology by Gutiérrez, Diana et al.
RESEARCH ARTICLE
Monitoring in Real Time the Formation and
Removal of Biofilms from Clinical Related
Pathogens Using an Impedance-Based
Technology
Diana Gutie´rrez, Claudio Hidalgo-Cantabrana, Ana Rodrı´guez, Pilar Garcı´a,
Patricia Ruas-Madiedo*
Instituto de Productos La´cteos de Asturias–Consejo Superior de Investigaciones Cientı´ficas (IPLA-CSIC),
Villaviciosa, Asturias, Spain
* ruas-madiedo@ipla.csic.es
Abstract
Bacteria found in diverse ecosystems grow in a community of aggregated cells that favors
their survival and colonization. Different extracellular polymeric substances are used to
entrap this multispecies community forming a biofilm, which can be associated to biotic and
abiotic surfaces. This widespread and successful way of bacterial life, however, can lead to
negative effects for human activity since many pathogen and spoiling bacteria form biofilms
which are not easy to eradicate. Therefore, the search for novel anti-biofilm bio-active mole-
cules is a very active research area for which simple, reliable, and fast screening methods
are demanded. In this work we have successfully validated an impedance-based method, ini-
tially developed for the study of adherent eukaryotic cells, to monitor the formation of single-
species biofilms of three model bacteria in real time. The xCelligence real time cell analyzer
(RTCA) equipment uses specific microtiter E-plates coated with gold-microelectrodes that
detect the attachment of adherent cells, thus modifying the impedance signal. In the current
study, this technology allowed the distinction between biofilm-producers and non-producers
of Staphylococcus aureus and Staphylococcus epidermidis, as well as the formation of Strep-
tococcus mutans biofilms only when sucrose was present in the culture medium. Besides, dif-
ferent impedance values permitted discrimination among the biofilm-producing strains tested
regardless of the nature of the polymeric biofilm matrix. Finally, we have continuously moni-
tored the inhibition of staphylococcal biofilm formation by the bacteriophage phi-IPLA7 and
the bacteriophage-encoded endolysin LysH5, as well as the removal of a preformed biofilm
by this last antimicrobial treatment. Results observed with the impedance-based method
showed high correlation with those obtained with standard approaches, such as crystal violet
staining and bacteria enumeration, as well as with those obtained upon other abiotic surfaces
(polystyrene and stainless steel). Therefore, this RTCA technology opens new opportunities
in the biofilm research arena and its application could be further explored for other bacterial
genera as well as for different bio-active molecules.
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Introduction
Bacterial biofilms are complex communities composed of one or multiple species adhered to a
solid surface and surrounded by a polymeric extracellularmatrix secreted by the cells. The
matrix can be composed of polysaccharides, proteins, teichoic acids, nucleic acids and lipids,
which confer protection to the bacteria, physical structure and exchange of substances [1].
Inside the biofilm, gradients of nutrients and oxygen lead to differences in the physiological
state of bacteria depending on their location within the biofilm. Furthermore, both biofilm
development and dispersion is a fine regulated process where cell-cell communication is medi-
ated by quorum sensing systems [2] and di-GMP levels [3]. Currently, the first step of biofilm
formation involves the attachment of bacteria to biotic or abiotic surfaces in which different
structuralmicrobial molecules could be involved [4]. Biofilms are the most common life style
of microorganisms in nature and bacterial biofilms are especially relevant in clinical and several
industrial settings [5]. Indeed, many chronic infections are caused by pathogenic bacteria
growing in biofilms [6]. This is mainly due to their inherent resistance to host defense mecha-
nisms and to antimicrobial agents, including antibiotics and disinfectants. Biofilm structure
provides a reduced diffusion of these compounds, which turn them to be ineffective. In fact,
treatment of these infections is a serious challenge due to the reduced penetration of antibiotics
inside the biofilm [7]. In addition, the high proportion of cells having a low growth rate and/or
dormancy state also makes difficult the activity of antimicrobials [8].
Among bacteria involved in biofilm-associated infections, the species Staphylococcus aureus
and Staphylococcus epidermidis are especially relevant as cause of nosocomial infectionsmainly
linked to the colonization of implanted medical devices [9]. For these bacteria, the biofilm for-
mation is one of the major virulence factors associated with their ability to colonize human tis-
sues and abiotic surfaces [10]. A clear relationship has been established between production of
the extracellular poly-β-(1–6)-N-acetyl-glucosamine (PIA/PNAG) polysaccharide and viru-
lence in animal models of infection [11,12]. Biofilms of staphylococcal strains that lack PNAG
in their matrix, are based on the presence of surface proteins such as Bap (biofilm-associated
protein) [13] and SasG [14] or the fibronectin-bindingproteins (FNBPs). The extracellular
DNA (eDNA) derived from lysed bacteria is also a major component of staphylococcal bio-
films [15].
Dental plaque is another example of multiple species biofilm that could have potential clini-
cal implications due to caries occurrence following an oral-microbiota dysbiosis [16]. Strepto-
cocci seem to be involved in the initial steps of cariogenic biofilm formation [17,18]. Indeed, it
has been indicated that Streptococus mutans is the key player in the formation of the exopoly-
saccharidematerial (glucans) that constitutes the binding matrix to stick other bacteria. Some
specific glucosyltransferases (GTFs) involved in the synthesis of glucans are able to initially
bind to dental pellicle, or to adsorb to other non-adherent microorganisms; using sucrose from
diet as substrate, these enzymes initiate the formation of the polymericmaterial [19,20].
Thus, the obvious negative consequences of biofilm-forming pathogenic bacteriamake the
search for novel anti-biofilmmolecules a very active research area. To achieve this goal, the use
of fast, reliable and accurate technologies allowing the screening of active molecules is of piv-
otal relevance. In this work, we have assessed the suitability of an impedance-based instrument
as an alternative to standard methods (crystal violet staining and bacterial viable counting), for
monitoring the biofilm formation of representative biofilm-producing strains in real-time. The
suitability of this method to address the effect of two anti-biofilm compounds (endolysin
LysH5 and bacteriophage phi-IPLA7) on the development and removal of staphylococcal bio-
films was further evaluated.
Real-Time Pathogen’s Biofilm Monitoring
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Material and Methods
Bacterial strains and culture conditions
Several strains of S.mutans, S. aureus and S. epidermidis, from different origin and properties,
were selected as model bacteria able to form biofilms (Table 1). As standard culture conditions
S.mutans was grown in BHI (Brain Heart Infusion, Oxoid, Basingstoke, Hampshire, UK) at
37°C under 5% CO2 atmosphere, and Staphylococcus spp. in TSB (Tryptic Soy Broth, Scharlau,
Barcelona, Spain) with 0.25% glucose (TSBG) at 37°C with shaking. Bacteria from stocks (at
-80°C) were plated onto the corresponding agar media (containing 2% agar) and incubated for
24 or 48 hours. Afterwards, single colonies were picked up to inoculate BHI or TSBG and cul-
tured overnight; these cultures were used to inoculate (2% vol/vol) fresh media which were
incubated for 18±1 h, under standard conditions, to obtain the cells for further experiments.
Monitoring biofilm formation in real time
The real time cell analyzer (RTCA) xCELLigence (ACEA Bioscience Inc., San Diego, CA)
equipment, based on impedancemeasurement, was used to monitor the formation of bacterial
biofilms. This equipment has initially been developed to detect variations in the impedance sig-
nal (expressed as cell index, CI) due to the attachment and growth of adherent eukaryotic cells
upon the gold-microelectrodesplaced in the bottom of E-plates (ACEA Bioscience Inc.), which
have a surface equivalent to 96-wells standard microplates. The RTCA-DP platform used in
our work has three holder units to place three independent 16-well E-plates [25]. The equip-
ment was introduced into incubators at 37°C (with or without 5% CO2) and after bacterial
seeding, the CI was recorded every 10 min during the incubation period.
The underlying principle behind this method for monitoring bacterial biofilm formation is
depicted in Fig 1. When the bacterial culture is added, the basal CI value is “0” because there is
not opposition to the pass of the current through the gold microelectrodesplaced in the well.
Once that the bacteria adhere to the microelectrodes and they begin to proliferate, there is a
modification of the electric impedance and the CI starts to increase. Polymeric material can be
formed during this proliferative state contributing, as well, to the modification of the imped-
ance signal. The maximum CI is reached when the opposition to the pass of the current is kept
constant, indicating that the surface of the microelectrode is covered by the biofilmwhich has
reached the stationary phase. This CI value remains constant throughout the maturation of the
biofilm decreasing afterwards, once the biofilm initiates the detachment phase (step not
shown).
Table 1. Strains of Streptococcus mutans and Staphylococcus ssp. used in this study.
Species Strain Origin Properties * Reference
S. mutans CI2366 Clinical isolate [21]
NCTC10449 Culture collection Type strain [21]
S. aureus 15981 Clinical isolate PNAG producer [22]
ISP479r Clinical isolate PNAG producer [22]
132 Clinical isolate PNAG producer [23]
V329 Bovine subclinical mastitis Bap protein producer [13]
CH1368 - Non biofilm producer -
S. epidermidis F12 Breast milk of lactating woman PNAG producer [24]
CH48 - Non biofilm producer -
* PNAG (PIA/PNAG): poly-β-(1–6)-N-acetyl-glucosamine polysaccharide.
doi:10.1371/journal.pone.0163966.t001
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S. mutans and Staphylococcus spp. biofilm formation
Standardized S.mutans cultures (counts about 109 CFU/ml) were washed twice with PBS and
diluted (1/10, vol/vol) in BHI. These bacterial suspensions were used to inoculate (1/10, vol/
vol) 1 ml of different culture media: BHI, BHI supplemented with 2% glucose, BHI supple-
mented with 0.2% sucrose or BHI supplemented with 1% sucrose. Finally, 200 μl of these inoc-
ulated media were seeded into two duplicated wells (~`2 × 106 cells/ well). The E-plates were
then connected to the RTCA-DP holder which had been previously placed for 2 hour into the
incubator (37°C with 5% CO2). The biofilm formation was followed for 24 h, by recording the
impedance signal (CI) every 10 min. The experiment was repeated with biological (indepen-
dent bacterial cultures) replicates.
The staphylococcal biofilm formation was carried out as describedpreviously [26]. Briefly,
standardized grown cultures were diluted up to 107 CFU/ml in fresh TSBG broth. Then, 200 μl
of this suspension (~ 2x106 cells/ well) were poured into the E-plates, which were connected to
the RTCA-DP holder pre-warmed at 37°C. Biofilm formation was followed, as previously indi-
cated, in independent biological replicates. In parallel, for comparison purposes Staphylococcus
spp. biofilms were performed under the same conditions on other abiotic surfaces, such as
polystyrene (TCMicrowell 96U w/lid nunclon DSI plates, NUNC, Thermo Scientific,Madrid,
Spain) and stainless steel (10×10×1 mmAISI 304 stainless steel coupons, Acerinox S.A.,
Madrid, Spain). Coupons were previously autoclaved at 121°C for 20 min, placed into a 24 flat-
bottommicrotiter plate and inoculatedwith 1 ml (~ 106 cells/well) of staphylococcal cultures.
Bacteriophage-based treatments on Staphylococcus spp. biofilm
formation and removal
Additional experiments were carried out with the RTCA in order to check the effect of a bacterio-
phage and a bacteriophage-encodedendolysin on biofilm formation. In this case, 200 μl of S.
aureus 15981 suspension (2 × 106 cells/well) made in TSBGwas supplemented with 0.15 μM of
the endolysin LysH5, purified as described in a previous work [27]. Similarly, 200 μl of S.
Fig 1. Schematic drawing of the basis to monitor bacterial biofilm formation by the xCellingence equipment. Standard
E-plates (16-wells) and magnification of one of the wells coated with gold microelectrodes (A). Evolution of the “cell index” (CI),
which derived from the electric impedance, throughout the different steps of bacterial biofilm formation by the strain S. aureus
15981 (B).
doi:10.1371/journal.pone.0163966.g001
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epidermidis F12 suspensionmade in TSBGwas infectedwith the bacteriophage phi-IPLA7 (MOI
100) [28]. These bacterial suspensions, and their corresponding controls without treatment, were
immediately added to E-plates and biofilm´s formation was monitored at 37°C for 24 h.
To assess biofilm elimination, 100 μl of S. aureus 15981 (106 CFU/ml) in TSBGwere added to
each E-plate and biofilm growth was monitored for 8 h at 37°C. At this time, once the biofilms
reached the stationary phase (CI constant), 100 μl of different LysH5 concentrations (from 0.05
to 2.88 μM, diluted in TSBG)were added; a control sample without LysH5 addition was also
included as reference. The effect of LysH5 over preformed biofilms was monitored at 37°C dur-
ing additional 6 h. This experimental procedure was repeated three times. The RTCA software
1.2.1 (ACEA Bioscience)was used for data normalization [29]: CI results obtained from each
LysH5 concentration were referred to the CI obtained at the time of the bio-active addition and,
afterwards, they were subtracted from the corresponding value of the reference sample.
Biofilm detection and assessment
Crystal violet staining was used to determine the total biomass adhered to the gold-microelec-
trodes of the E-plate wells or to other abiotic surfaces. Culture medium supernatants were care-
fully removed and biofilms were washed twice with PBS buffer (137 mMNaCl, 2.7 mMKCl,
10 mMNa2HPO4 and 2 mMKH2PO4; pH 7.4), air-dried for 15 min at room temperature, then
stained with crystal violet (0.1% wt/vol) and, finally, gently washed with tap water. S.mutans
stained biofilms were photographed, whereas those of Staphylococcus spp. were de-stained with
acetic acid (33%) and the absorbance of the supernatants was measured at 595 nm in a Micro-
plate Benchmark Plus (BioRad, Hercules, CA) spectrophotometer.
Counts of S.mutans planktonic cultures were carried out after 24 h incubation in the four
culture media used to test biofilm formation. For counting, serial dilutions were made in
Ringer ¼ solution and plated on agar-BHI plates, which were incubated for 48 h under stan-
dard conditions. Counts of Staphylococcus spp. in biofilms were performed to determine the
number of adhered cells that form the biofilm. For this purpose, wells were washed twice with
PBS buffer and adhered cells were released by scratching twice with sterile swabs which were
immersed in 9 ml of PBS buffer. The biofilm was further disaggregated by vigorous shaking for
1 min. Finally serial dilutions were plated onto TSA and incubated at 37°C for 24 h.
Statistical analysis
The statistical analysis of the different measured parameters was performedwith, at least, four
data: two independent biological replicates each measured in duplicate. For this purpose, the
statistical package IBM SPSS Statistics for Window Version 22.0 (IBM Corp., Armonk NY)
was used to assess differences by means of one-way ANOVA tests. Additionally, when needed,
the Duncanmean comparison test was used (p<0.05) to determine the differences among
strains, culture media used and/or bacteriophage or LysH5 treatments. The legend of each fig-
ure or table shows the comparison performed.On the other hand, linear regression equations
among different numeric parameters were calculated in order to obtain the coefficients of
determination (R2) which show how well data fit to the regression line equations.
Results
The RTCA method monitored sucrose-dependent S. mutans biofilm
formation
The type strain S.mutans NCTC10449 was initially used to test the suitability of the RTCA
technology to monitor the biofilm formation of this bacterium in real time. Since the
Real-Time Pathogen’s Biofilm Monitoring
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occurrenceof an oral biofilm in which S.mutans could be involved is directly correlated with the
presence of sucrose in the environment, four BHI-basedmedia were tested. Results obtained
showed an increase in the CI signal in the media containing sucrose or high percentage of glu-
cose, whereas in BHI, which is formulated by the commercial brand with 0.2% glucose, had no
appreciable increase in the CI (Fig 2). The maximumCI values were reached after 8 h of incuba-
tion in all media, and the highest (p<0.05) value was obtained with 1% sucrose (CI around 0.5),
followed by 0.2% sucrose and 2% glucose, which indicates that high biomass was adhered to the
E-plate under the first condition. Of note it is the absence of signal interfering with the imped-
ance measurement due to the ionic composition of the four culture media (Fig 2) which are
based on BHI but having different concentrations of glucose or sucrose. The clinically isolated
CI2366 strain was used to corroborate that the RTCA technologywas detecting the formation of
a biofilm. In this case, also a direct correlation betweenCI and presence of sucrose in the culture
mediumwas denoted (Fig 3A). Besides, it seems that the clinical isolate was able to form stronger
biofilms upon the gold-microelectrodes than the type strain since the CI indexmeasured 8-h
post-seedingwas higher in all conditions (p<0.01) reaching a maximum value of 0.6. Crystal vio-
let staining confirmed the presence of a biofilm in the corresponding inoculatedwells, which
seems to be weaker in the BHI mediumwithout additional carbon source supply (Fig 3B).
Finally, it is remarkable that the observedeffect was not due to differences in the ability of the
two strains to grow in the four culture media, given that the counts of planktonic cultures were
similar, or even higher (p<0.05), in the absence of sucrose (Fig 3C).
The RTCA method detected strain-dependent Staphylococcus spp.
biofilm formation
Two species of Staphylococcus, typically involved in biofilm production, were tested to further
confirm the suitability of this impedance-basedmethod to monitor formation of other bacterial
Fig 2. Variation in the cell index (CI) during S. mutans NCTC10449 biofilm formation, at 37˚C under 5%
CO2, depending on the carbon source added to the culture medium. At 8 h of incubation time, those values
that have not a common letter are statistically different according to the Duncan mean comparison test (p<0.05).
From this point of time, the percentage of coefficient of variation (100*SD/mean) of the data typically varied from
1% to 10%.
doi:10.1371/journal.pone.0163966.g002
Real-Time Pathogen’s Biofilm Monitoring
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biofilms. The four biofilm-producing S. aureus strains showed an increase in the CI signal
which was not detected in the non-biofilm producing CH1368 strain (Fig 4A). Besides, statisti-
cal differences were detected among strains at different incubation times (S1 Table) and the
maximum CI values reached varied between 0.06 and 0.19, depending on the strain considered.
In this regard, the differences in the CI were not further correlated with the nature of the poly-
mericmaterial forming the biofilm. In fact, the protein matrix producer V329 showed the high-
est CI for the first 15 h, decreasing afterwards, while the PIA/PNAG-polysaccharide producers
ISP497r and 15981 reached higher CI from this time to the end of incubation period.However,
the strain 132, also synthesizing PIA/PNAG, showed the lowest CI values throughout the incu-
bation period (Fig 4A, S1 Table). Similar results were obtained using data of absorbancemea-
sured after crystal violet staining in all biofilms and they were also correlated with the strain
regardless the type of matrix produced (Fig 4B, S1 Table). The bacterial counts of the S. aureus
adhered to the gold-microelectrodesalso showed statistical differences (Fig 4C, S1 Table); all
biofilm-producing strains reached the maximum counts around 6.0 to 6.5 log units. Results
Fig 3. Variation in the cell index (CI) during biofilm formation, at 37˚C under 5% CO2, of S. mutans NCTC10449 (type strain) and CI2366 (clinical
isolate) depending on the carbon source added to the culture medium. At 8 h of incubation, the presence of the asterisk indicates that CI values were
statistically different according to one-way ANOVA tests (p<0.05); the coefficient of variation (100*SD/mean) of data typically varied from 2% to 16% for
strain CI2366, and from 1% to 30% for strain NCTC10449 (A). Crystal violet staining of the biofilms NCTC10449 and CI2366 formed in the E-plate (B).
Counts (Log CFU/ml) of planktonic cultures of both strains in different culture media. Within each strain, the bars that do not share a common letter are
statistically different according to ANOVA and Duncan mean comparison tests (p<0.05) (C).
doi:10.1371/journal.pone.0163966.g003
Real-Time Pathogen’s Biofilm Monitoring
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obtained with the S. epidermidismodel also confirm the capability of the RTCA technology to
monitor this biofilm formation; CI values only increased in wells seededwith the biofilm-pro-
ducing F12 strain, as well as crystal violet absorbance and the number of bacteria adhered to
gold microelectrodes (Fig 4A, 4B and 4C, S1 Table).
It is truly remarkable that CI measurement was the only technique allowing the clear dis-
tinction among the four S. aureus strains. According to crystal violet staining the strains
ISP479r and 132 could be both classified as weak biofilm producers given that no statistical dif-
ferences were detected between them (S1 Table). Similarly, the stronger biofilm producers
15981 and V329 did not show any significant difference either with the staining method or
with the counting technique. The CI determination allowed, therefore, a better classification of
the strains based on their ability to adhere to the abiotic surface since the standard methods
(bacterial viable counting and crystal violet staining) could probably be more influenced by the
intrinsic characteristics of each strain, such as the nature of the polymericmaterial involved in
adhesion or the bacterial growth rate, among other factors [30]. In this regard, the coefficients
of determination (R2) obtained from linear regression equations comparing (two by two) data
of CI, absorbance and bacterial counts, were calculated to correlate the three methods used for
biofilm quantification purposes (Table 2). It is remarkable that only in the biofilm-producing
strains, either from S. aureus or S. epidermidis, the R2 values were, in general, higher than 0.93,
thus indicating a good fit between data. On the contrary, there was not linear relationship for
the two non-biofilm producers in none of the three comparisons performed (Table 2).
It should be noticed that the use of RTCA technology implies that biofilm is formed upon
gold surface which is not the standard material used for these studies. Therefore, in order to
check whether this material could have influence on the results obtained, biofilms were also
performed under the same conditions upon polystyrene and stainless steel surfaces. The absor-
bance after crystal violet staining was measured in biofilms formed upon the three materials.
The linear regression coefficientsR2 obtained with the five biofilm-producing strains showed
good fit values, higher than 0.97 (S2 Fig) among the three materials tested. This indicates that
Fig 4. Variation in the cell index (CI) during biofilm formation at 37˚C of different S. aureus and S. epidermidis biofilm producers (ISP479r,
15981, 132 or V320 and F12, respectively) and no-biofilm producers (CH1368 and CH48, respectively). TSB+0.25% glucose was the culture
medium used in the experiment (A). Absorbance (595 nm) measured after crystal violet staining of samples collected at different times during the biofilm
formation in E-plates of the strains under study (B). Counts (Log CFU/ml) of cells collected from the biofilms formed in the E-plates by the strains under
study (C). Statistical differences among strains at three sampling points (8, 16 and 24 h) are collected in S1 Table, which also shows representative mean
and SD values.
doi:10.1371/journal.pone.0163966.g004
Table 2. Linear regression coefficients of determination (R2) calculated from the parameters measured in Staphylococcus spp. strains biofilm
producers and non-producers. At least five sampling points along the incubation time were used for the linear regression calculation (see in supplemen-
tary material “S1 Fig” the linear regression equations calculated for the biofilm producers).
Linear regression coefficients (R2)*
Species Strain Biofilm forming ability CI vs. Abs CI vs. Log CFU Abs vs. Log CFU
S. aureus 15981 Biofilm producer 0.9860 0.9707 0.9529
ISP479r Biofilm producer 0.9558 0.9692 0.6908
132 Biofilm producer 0.8828 0.9719 0.9849
V329 Biofilm producer 0.9393 0.9605 0.9873
S. epidermidis F12 Biofilm producer 0.9413 0.9521 0.9814
S. aureus CH1368 No-biofilm producer 0.1128 0.5074 0.0116
S. epidermidis CH48 No-biofilm producer 0.1895 0.6201 0.0171
* CI, cell index; Abs, absorbance; CFU, colony forming units.
doi:10.1371/journal.pone.0163966.t002
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the S. aureus and S. epidermidis strains studied were able to form similar biofilms on the three
abiotic surfaces.
Validation of RTCA method to monitor the inhibition of Staphylococcus
spp. biofilm formation, and its removal, by bacteriophage and phage-
derived proteins
One of the most active areas of research in staphylococci biofilm studies is the screening of new
bio-actives able to avoid the progression or to eliminate these microbial structures. Thus, we
have applied the RTCA method to evaluate the capability of a staphylococcal bacteriophage
and an endolysin to modify biofilm formation dynamics. S. aureus 15981 suspensions treated
with 0.15 μM LysH5 immediately before seeding the E-plates were not able to reach CI values
similar to the control sample (Fig 5A); the statistical differences between control and treated
samples were detected around 6-h post-seeding (S2 Table). Similarly, the infection of S. epider-
midis F12 with bacteriophage phiIPLA7 (MOI 100) also inhibited the biofilm formation and
Fig 5. Inhibition of the biofilm formation by S. aureus 15981 due to the addition of endolysin LysH5 (0.15 μM) to the culture medium
TSBG, and by S. epidermidis F12 due to the addition of the bacteriophage phi-IPLA7 (MOI 100) to TSBG expressed as variation of the CI
during biofilm treatment; asterisks show the first incubation time after which two or more consecutive values of CI were statistically different
(p<0.05), according to one-way ANOVA tests (S2 Table) (A). Counts (Log CFU/ml) of cells collected, after 24 h of treatment, from the biofilms
formed in the E-plates; within each strain, the asterisks (p<0.001) show statistical differences according to ANOVA (B).
doi:10.1371/journal.pone.0163966.g005
Real-Time Pathogen’s Biofilm Monitoring
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the statistical differences, with respect to the non-treated bacterial suspension, were first
detected after 4 h of incubation (Fig 5A, S2 Table). After 24 h of incubation, counts of the
remaining adhered cells also confirmed these results since they were reduced by 2 log-units in
the wells treated with the endolysin and by 4 log units in the wells treated with the phage,
respectively, compared with the untreated controls (Fig 5B).
The effect of LysH5 on 8 h preformed S. aureus 15981 biofilms was also tested using differ-
ent concentrations of the endolysin. After 6 h of incubation, the values of the normalizedCI
(Fig 6A) showed that, in the range tested, 0.36 μM was the minimum effective dose that
resulted statistically different (p<0.05) from the control sample (without LysH5). Lower doses
were not able to eliminate the biofilms given that the normalizedCI value did not differ from
the control. At higher doses, the ability to detach the preformed staphylococcal biofilm was
detected at shorter incubation periods. Indeed, the lowest normalizedCI was achieved 2 h
post-treatment in the presence of both 1.44 and 2.88 μM of LysH5; longer exposures to these
concentrations did not improve the capability of LysH5 to remove the biofilm. These RTCA
results were further validated by a final end-point method (after 6 h of incubation at 37°C), i.e.
the crystal violet staining using both qualitative (photo) and quantitative (absorbance)mea-
surements (Fig 6B).
Finally, it is worth noting the reproducible results obtained with the RTCA in our model
bacteria, supported by the acceptable (lower than 38%) coefficient of variation (SD/mean, a
measure of data dispersion) determined. Besides, another example illustrating the high repro-
ducibility of the RTCA methodologyhas been provided by the strain S. aureus 15981 in three
independent experiments; in all of them the maximum CI (around 0.18) was reached after 6–8
h of incubation (Fig 1, Fig 4 and Fig 5).
Discussion
The ability of bacteria to adhere to different surfaces resulting in the formation of a biofilm
seems to be a ubiquitous bacterial feature since it provides an advantage to resist adverse
Fig 6. Removal of 8 h preformed S. aureus 15981 biofilms by endolysin LysH5 (added to TSBG from 0.05 to 2.88 μM) reported as variation of
the normalized cell index (CI). At the final time, values having distinct letter are statistically different (p<0.05) according to the Duncan mean
comparison test; the coefficient of variation (100*SD/mean) of these data typically varied from 5% to 38% (A). Absorbance (595 nm) measured after
crystal violet staining of biofilms after 6 h of LysH5 treatment. Values with asterisks are statistically different (p<0.05) from the reference control (without
LysH5 addition) according to one-way ANOVA tests. The photograph on the top shows the biofilms formed in the E-plates, in the presence of different
concentrations of LysH5, stained with crystal violet (B).
doi:10.1371/journal.pone.0163966.g006
Real-Time Pathogen’s Biofilm Monitoring
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environmental conditions and facilitates cells dispersion to colonize different ecological niches
[31]. As mentioned above, the microorganisms growing in biofilms have negative implications
in health but also can affect different industrial processes such as, among others, food
manufacturing [32]. The great number of biofilms implications worldwide has fueled the
research in this field; in particular, the molecularmechanisms involved in biofilm formation,
the characterization of biofilm structure, or the development of systems to control the biofilm
formation or to facilitate its removal have been approached. For this purpose, one of the most
frequently used in vitro biofilmmodel is the microtiter plate (MTP)-based system where bio-
films grow on the bottom and the walls of microtiter-plate wells, or onto the surface of coupons
placed on the bottom of wells. These biofilms are mostly visualized after crystal violet staining
or using other labeling (e.g. fluorescence probes) approaches. This MTPmethod is a closed sys-
tem that facilitates the screening of the potential biofilms producers in different nutrients and
environmental conditions [33], as well as testing the sensitivity of biofilm-forming bacteria to
different antimicrobials [34]. However, processing of biofilms to calculate biomass and adhered
cells in this MTP-based system is a time consuming, end-point and label-dependentmethod;
for this reason, alternative devises are currently under development to continuously monitor
biofilm formation, such as those using time-lapsed image recording [35,36], methods for mass
measurement by using piezoelectric tuning fork [37], or those based on electrical impedance
spectroscopymeasurements [38,39]. In the current work we have analyzed the suitability of the
xCELLigence (RTCA) equipment, a non-invasive, label-free, real time monitoring system
based on impedance (CI) recording, to follow biofilm formation. This technologywas previ-
ously used to measure biofilm formation in one strain of S. aureus [40] and, more recently, to
follow biofilm disruption after antibiotic and selenium-nanoparticles treatments in two strains
of the same species [41]. However, in our study we have validated this methodologyusing nine
strains (including non-biofilm producing controls) from three model species, in comparison
with two conventional methodologies and two abiotic surfaces.
In our study the results obtained with S.mutans clearly showed that the RTCA equipment
was able to monitor the formation of biofilms upon the gold-microelectrodesof the E-plates,
which occurredwhen sucrose was present in the culture medium especially at higher concen-
trations (1%). It has been reported that sucrose is a cariogenic sugar, favoring dental biofilm
formation, since it is used as fermentable substrate by pro-cariogenicmembers of oral micro-
biota, promotes higher enamel mineral loss than other sugars, and also serves as substrate for
streptococcalGTFs involved in the synthesis of glucans [42]. Additionally, differences on
sucrose-dependent adherence were also monitored between the clinical isolate (strain CI2366)
and the type strain (NCTC10449); this fact underlines that the impedancemethod was able to
distinguish different biofilm formation capabilities, which it is known to be a strain-dependent
trait in S.mutans [43,44]. Regarding staphylococcal biofilms, the impedance CI increased
throughout time only in those positive biofilm-forming strains (15981, ISP479r, 132, V329 and
F12), also in a strain dependent manner regardless composition of the biofilmmatrix. With the
only exception of S. aureus V329 strain, the highest CI values were detected at 24 h being
higher than those observedpreviously for S. aureus ATCC6538 [40]. The strain V329 showed a
continuous CI decrease, after the maximum reached at 16 h, which can be explained by dis-
persal/detachment phenomena that occur in staphylococcal biofilms during the maturation
process [45]. These observations suggest that the RTCA equipment was sensitive enough to
detect differences among biofilm producing conditions and biofilm producer strains. As
expected, at defined incubation times higher absorbance values (as expression of biomass pro-
duction) were detected in biofilm-producing strains after crystal violet staining than in non-
producers, as well as higher counts of adhered cells. Remarkably, a strong correlation was
obtained (R2 0.93) when CI index was compared either with absorbance values or adhered
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cells counts in biofilm-producing strains. This was also observed (R2 0.98–0.99) in absor-
bance values when compared biofilm developed on the gold electrodes (hydrophilic) with
those developed either on polystyrene (hydrophobic) wells or stainless steel coupons (hydro-
philic). This is not a surprising result since da Silva Meira and co-workers [46] observed similar
capability of staphylococcal isolates to adhere and form biofilms on hydrophilic or hydropho-
bic surfaces. Therefore, the good correlation obtained among all parameters tested using either
standard methods or the RTCA technology, indicates that the latter is a suitable alternative to
study biofilm formation in real time. The CI index values reached during bacterial biofilm for-
mation were about 10-times lower than those typically detected for adherent eukaryotic cells
[25]; this could be related to the different size between prokaryotic and eukaryotic cells.
The usual tolerance of biofilms to antimicrobial agents (antibiotics and disinfectants) has
promoted the emergence of alternative strategies to prevent the biofilm formation or removal
of preformed biofilms, such as the use of bacteriophages [47] and phage-encoded enzymes
[26,48]. Regarding this, the previously characterized bacteriophage phi-IPLA7 [28,49] and the
endolysin LysH5 [26,27] were used as antimicrobials to test their capability to inhibit staphylo-
coccal biofilm formation using the RTCA equipment. After 4–6 h of incubation, this technol-
ogy recorded significant differences in the CI values obtained for S. aureus 15981 and S.
epidermidis F12 in the presence of these antimicrobials, with respect to those in the control
samples, indicating that biofilm formation was prevented. Moreover, the usefulness of this
technique to monitor the efficacy of the endolysin LysH5 over a preformed staphylococcal bio-
film was demonstrated, and the most effective dose for biofilm removal was determined. Previ-
ous reports have also showed the inhibition in biofilm formation by bacteriophages [50–52]
and the successful removal of these structures by endolysins [26,53,54] as revealed by crystal
violet staining and viable cell counts. However, as far as we know, this is the first time that an
impedance-basedmethod has been used to show the ability of bacteriophages and phage lytic
enzymes to reduce or to remove the biofilms formed by staphylococcal strains.
Conclusion
Overall, results obtained in this work support that the impedance-basedRTCA monitoring is a
fast, reliable, and no-time consumingmethod than can be easily used, among other applications,
to perform screening of strains able to form biofilms, as well as to search for bio-actives that inter-
fere the biofilm formation, or remove the preformed ones, upon abiotic (gold) surface; this meth-
odology also allows to determine the antimicrobial effective concentration. Additional advantages,
with respect to the standard methods applied to biofilm research, are that it is not an end-point
method since continuously monitor the biofilm formation and it is a label-free technique given
that impedance curves are denoted in real-timewithout need of staining procedures. Regarding
disadvantages, it is worthmentioning the higher cost of the consumables (E-plates) of the RTCA
in comparison with those of the traditionalMTP-based systems. Besides, the impedance-based
technologies are highly dependent on the different ionic strength and concentration of multi-
valent ions of the electrically conductive solutions (buffer or culture medium) that could affect
biofilm formation and may also influence impedance signals. Therefore, it is worth noting that
this technology could not be suitable for all type of bacteria, but only for those able to form bio-
films upon goldmaterial and under ion-strength conditions that do not affect the basal impedance
signal. Thus, other model bacteria should be tested in order to find its range of applicability.
Supporting Information
S1 Fig. Linear regression equations and coefficientsof determination (R2) comparing, two
by two, the CI, absorbance and counts determined for each biofilm-producer staphylococcal
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strain.At least five sampling points, along the incubation time, were used for the linear regres-
sion calculation.
(PDF)
S2 Fig. Linear regression equations and coefficientsof determination (R2) calculated from
the absorbance data of Staphylococcus spp. biofilms formed in three abiotic surfaces, com-
pared two by two. Six sampling points, along the incubation time, were used for the linear
regression calculation.
(PDF)
S1 Table. Statistical analysis of biofilm-relatedparametersmeasured at three incubation
times.One-way ANOVA tests were performed to establish differences among strains belong-
ing to the same species ( p<0.001). When needed,mean comparison Duncan tests (p<0.05)
were carried out to assign differences among the strains; then, values that do not share a com-
mon superscript letter are different.
(PDF)
S2 Table. One-way ANOVAs to assess differences between control and treated (endolysin
LysH5 or bacteriophagephi-IPLA007) samples during biofilm formation.Differences were
considered stable when two or more consecutive p-values were lower than 0.05.
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